Of interest, CA attenuated NAFLD by downregulating fat synthesis genes such as fatty acid synthase (FAS) and Acetyl CoA Carboxylase (ACC-1), while promoting fatty acid oxidation [29]. This evidence concerns the gene FAS and metabolic dysfunction-associated steatotic liver disease.